The significance of the enhanced cellular phosphatidate and phosphatidylinositol turnover which occurs in response to specific extracellular messengers has been the subject of much interest and speculation. Until recently, much less attention has been paid to the presence of two quantitatively minor phosphorylated derivatives of phosphatidylinositol, known collectively as the polyphosphoinositides. These lipids have an extremely rapid ~V2p turnover rate and are presumed to be localized predominantly in the plasma membranes. Their turnover now appears to be linked with that of phosphatidate and phosphatidylinositol, and is discussed here in relation to the consequences of ligand-receptor interactions.
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Polypbosphoinositides as cell membrane components
Phosphatidylinositol (Phl), as well as two phosphorylated derivatives, phosphatidylinositol 4-phosphate (PhIP) and phosphatidylinositol 4,5-bisphosphate (PhlP2), are found in eukaryotic membranes (see Fig. 1 ). Because of the highly polar nature of these lipids, their quantitative extraction from tissues usually requires conditions of acidity or high ionic strength, and special thin layer chromatographic procedures are needed for their separation. These two factors may explain much of the past neglect of ligand-stimulated turnover of the polyphosphoinositides. An even more important factor is their rapid resynthesis, such that lipid breakdown can go unnoticed if it is not measured within seconds of ligand addition.
Subcellular distribution and metabolism
PhlP and PhlP2 are synthesized from endogenous Phl via sequential phosphorylation by ATP at the D-4 and D-5 positions of the myo-inositol moiety, under the action of specific kinases. In turn, phosphomonoesterases can dephosphorylate PhIP2 to PhIP and PhIP to Phi. The combined effects of the kinases and monoesterases result in the rapid equilibration of radioactivity in the gamma position of ATP with that of the inositide monoester functions. Alternatively, the entire headgroup of the polyphosphoinositides can be removed via phosphodiesteratic cleavage of the phospholipase C variety to yield the apolar product, diacylglycerol (DAG), together with inositol bis-or trisphosphate from PhlP or PhlP2, respectively. Available information from subcellular fractionation studies suggests that most of the relevant enzymes of polyphosphoinositide metabolism are present in both the plasma membrane and in the cytosol 2. The ability to form labeled PhlP2 from endogenous PhlP and [.,/.32p] ATP is a convenient measure of PhIP kinase, and has been demonstrated in purified plasma membrane preparations, as well as in plasma membrane-enriched tissues, e.g. brain, kidney, polymorphonuclear leukocytes and erythyrocytes 2. However, Phi kinase and/or PhIP kinase activity has also been documented in adrenal chromaffin granules, mitochondria, lysosomes, Golgi preparations and the nuclear envelope. Phi and PhlP kinases are Mg 2+-dependent, while the effects of Mg 2÷ and Ca 2÷ on the lipid phosphomonoesterase activities appear to vary with the tissue source of the enzyme. There is general agreement that Ca 2÷ ions at miUimolar concentrations selectively activate the phosphodiesterase(s), although the optimal concentration appears to depend upon the assay conditions employed. The enzymatic potential for degradation of the polyphosphoinositides in brain exceeds that of synthesis by one or two orders of magnitude, the most active being an apparent 'phospholipase C' phosphodiesteratic activity. Other possible pathways for polyphosphoinositide degradation, for example via phospholipase D or A2 activity, are minor. It thus appears that the breakdown of polyphosphoinositides via a type C phosphodiesteratic cleavage is likely to be of most physiological significance.
Receptors coupled to polyphosphoinositide turnover
The Gispen and colleagues have shown that the addition of adrenocorticotropin (ACTH) to these preparations results in an increase in polyphosphoinositide labeling 15. The effects are interpreted to reflect increased phosphorylation of PhlP to PhlP2. The presumed mechanism is inhibition by ACTH of the phosphorylation of a membrane protein of about M r 48 000 ('B50') whose phosphorylated form inhibits PhlP kinase. The B50 kinase is thought to be similar or perhaps identical to protein kinase C, found commonly in the cytosol of a number of tissues, particularly brain. While the protein kinase C is isolated from the cytosol and the B50 kinase is membrane-bound, free and bound forms of protein kinase C have been found in cultured cells, and their ratio is reportedly altered by the presence of phorbol esters 2°. ACTH administration, both in vivo and in vitro, results in a rapid increase in the chemical amounts of both PhlP and PhlP2 in the adrenal, with a time course similar to that reported for corticosterone production ~s. Direct additions of PhlP and PhlP2 to adrenal mitochondria "are reported to increase the rate of side chain cleavage of cholesterol to form pregnenolone, a result suggesting that the polyphosphoinositides play a significant role in steroidogenesis.
Calcium and the polyphosphoinositides
Since many receptor-ligand actions that affect polyphosphoinositide turn-,/~lEx 
. Cyclic turnover of inositol lipids. The originally proposed cycle (upper left) of Phi ~> DA G -> PhA -> CDP-DAG -> Phi is now extended to include the polyphosphoinositides. While phosphodiesteratic cleavage of PhlP is indicated, there is better evidence for stimulated Phil', breakdown following receptor-ligand (RL) activation. The cycle on the right demonstrates the sequential breakdown of lp~ to inositol. The breakdown of IP 1 is blocked by Li +. Cellular inositol is supplied exogenously (I~ 0 or produced by degradation of L-myo-inositol phosphate (IP~) formed via cyclization o( glucose-6-phosphatc (G6P).
over exert their physiological effects by increasing intracellular Ca 2+, it is not surprising that a direct role for Ca 2+ in the metabolism, of these phospholipids has also been proposed. Central to this issue is the question of whether the increased lipid turnover either (1) is the consequence of an increase in cytosolic Ca z+, (2) mediates the increase in Ca 2+ permeability, or (3) parallels, but is independent of, Ca 2+ mobilization. In support of the first possibility is the finding that the muscarinic cholinergic or oq-adrenergic stimulated breakdown of PhIP2 in iris smooth muscle requires added Ca 2+, is abolished ir~ the presence of EGTA or inhib,ors of Ca 2+ translocation, a ¢ .: can be induced by the addition of Ca 2+ ionophores 6. In hepatocytes, vasopressin stimulation of PhIP2 breakdown is abolished in the presence of EGTA 7. Furthermore, the introduction of Ca 2+ into a nerve ending preparation with the divalent cation ionophore A23187 stimulates the breakdown of PhIP and PhIP2, under conditions in which inositol phosphates accumulate 2~. On the other hand, the stimulated breakdown of PhIP2 in the parotid gland, platelet and pancreas appears insensitive to Ca 2+ depletion, or is at least less so than the attendant physiological responses. This latter result supports the second possibility, namely that PhIP2 breakdown reflects a molecular mechanism whereby cells gate Ca 2+, so that increased turnover of PhIP2 is not regulated by the increase in intracellular Ca 2+. An alternative explanation is that Q these cells are not easily depleted of Ca 2+ in the presence of extraceUular EGTA. The various results, taken together, are compatible with the interpretation that polyphosphoinositide turnover is Ca2+-dependent, but may not be Ca2+-regulated. Because of the known high affinity of polyphosphoinositides for binding Ca 2+ ions, their plasma membrane localization and potential for rapid degradation upon receptor activation, these lipids have been considered as a possible reservoir of cell Ca 2+. It has been demonstrated that the Ca2+-binding activity of erythrocytes increases directly with the state of inositide phosphorylation 22. Similarly, phosphorylation of renal brush border membrane vesicles results in stimulation of Ca 2+ intake, with increased phosphoinositide and PhA content 23. It is less certain, however, that the chemical amounts of Ca 2+ bound to polyphosphoinositides suffice to account for the increase in cytosolic Ca 2+ resulting from receptor activation. Calculations of amounts of Ca 2+ released from PhlP2 in hormone-stimulated hepatocytes indicate that only a small fraction of the measured Ca 2+ released from these cells could be derived from the polyphosphoinositide pool. In the case of platelets, the calculated amounts of Ca 2+ released from PhlP 2 following ADP addition could, however, account for an increase in intracellular Ca 2+ by 10 pI,M 13. These observations must be tempered by considerations of conditions in vivo. For example, these various 55 calculations assume that Ca 2+ is the sole cation present. Although cytosolic Mg 2+ is in fact present at greater concentration than Ca 2+ and binds to the polyphosphoinositides with similar affinity, Mf + or Ca 2+ salts of the polyphosphoinositides probably have different affinities for the enzymes for which they are substrates.
It is alternatively possible that products of phosphoinositide turnover trigger the rise in cell Ca 2+. For example, phosphatidate has been shown to have Ca 2+ ionophore activity, as have arachidonate metabolites. Another candidate is IP3, a product of PhlP2 degradation. Preliminary reports indicate that IP3 can increase Ca 2+ effiux from cells under specified conditions 24. In platelets, the physiological response resulting from a rise in intracellular Ca 2+ can be mimicked by accumulation of DAG, this effect being mediated through activation of protein kinase C (Ref. 25) . Thus, the production of both DAG and IP3 may be necessary for expression of a full response, In fact, experimentallyinduced increases in intracellular Ca 2+ and DAG elicit synergistic rather than additive cell responses in the platelet 26.
Inositide turnover in the nervous system
While much of our present knowledge of the polyphosphoinositides has been obtained with non-neural preparations, it is likely that the role of these lipids in the central nervous system will come under increasing scrutiny. Brain contains high concentrations of polyphosphoinositides localized to two distinct pools: a metabolically stable pool associated with myelin and a more labile pool present in neuronal or glial plasma membranes 27. Nerve ending preparations support a muscarinic cholinergic stimulation of PhA and Phi labeling, which has been localized post-synaptically 2~. Membranes from nerve ending preparations contain Ca2+-activated phosphodiesterase, capable of the rapid degradation of endogenous PhlP2 and PhlP 29. Although there is evidence for a neurotransmitter-linked effect on PhlP and PhIP2 turnover, direct stimulation of inositol lipid breakdown in the CNS and corresponding release of inositol phosphates is difficult to demonstrate. However, the observation by Allison et al. 3° that lithium administration to rats results in an intracerebral accumulation of IP1, has been successfully exploited & vitro. A stimulated release of IP~ can be detected following the addition of a number of neurohorulones to brain slices incubated in the presence of Li-(Ref. 31 ). This effect of Li + is believed to be due to an inhibition of the phosphatase that degrades IPt (Fig. 2) . The increase in IP~ could result from the phosphodiesteratic cleavage of Phi, but recent evidence favors an initial release of IP3 (Ref. The functions of the tissues implicated directly or indirectly in reproduction processes are under the control of the sex steroid hormones. In the female, the hypothalamic and pituitary hormones regulate the secretion of oestrogens and progesterone by the ovary; the feedback by these steroids controls the pattern of sexual behaviour and reproductive capacity. For the necessary fine tuning of hormonally regulated processes in the target tissues, the organism must ensure that a response to the same stimulus at different times can be amplified or attenuated according to need. Progesterone, in addition to the effects it exerts on the differentiation and function of some tissues, seems to play the role of this 'second handle' for the oestrogen-dependent processes in many organs related to reproductive function in the female. Its antagonism of oestrogen has long been known 1, and more recent evidence demonstrates that the same hormone can potentiate, amplify or sometimes mimic oestrogenic activity. The amplitude of the response of the tissue to progesterone depends in turn on the preceding oestrogen 'priming' of the tissue with resulting synthesis and accumulation of progesterone receptors. In this review we summarize and analyse these apparently contradictory roles of progesterone and their possible mechanisms. 
Effect of progesterone alone
Although the name progesterone indicates that the hormone is necessary for the maintenance of gestation, it is also an important factor in the regulation of reproductive functions in lower animals such as birds and amphibians. All the tissues related to female reproduction that have been studied possess intracellular proteins ('receptors') with high affinity for progesterone and related molecules. The specificity of binding to progesterone receptors correlates well with the biological activity of the respective compound, supporting the hypothesis that the receptors are involved in the mediation of hormone action 2.
In the absence of hormone, virtually all progesterone receptors are recovered in the high-speed supernatant fraction ('cytosol') of tissue homogenates, and display certain properties characteristic of what has been defined as the 'native' (non-activated) form. These include, in particular, low binding to isolated nuclei and to certain natural (DNA) or synthetic (phosphocellulose; ATP-agarose) polyanions, as well as a large size indicated by a sedimentation coefficient of 8S in density gradients. The actual progestin-binding sites are situated on two subunits. A (mol. wt -79 000) and B (mol. wt --110 000), which have been
